Razvi, S <br/><br/>
Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.  [electronic resource] 

 -  Clinical immunology (Orlando, Fla.)  Dec 2001 
 - 284-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1521-6616 
<br/><br/><label>Standard No.: </label>10.1006/clim.2001.5132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--therapeutic use<br/>Child<br/>Drug Contamination<br/>Hepatitis C--drug therapy<br/>Humans<br/>Immunoglobulins, Intravenous--adverse effects<br/>Immunologic Deficiency Syndromes--drug therapy<br/>Interferon-alpha--therapeutic use<br/>Middle Aged<br/>Ribavirin--therapeutic use<br/>Surveys and Questionnaires<br/>Treatment Outcome